The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

Fund manager Jonathan Boyar and his team highlighted several stocks that could get a boost thanks to activist shareholders.

As traders and investors look ahead to 2025, the dividend sector is set to draw considerable interest, as market participants ...

Investors can look forward to continued growth of Royalty Pharma's bottom line and dividend payout ... Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions ...

W.P. Carey and Royalty Pharma offer above-average dividend yields ... Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

The firm has roots tracing back to 1849, and it has a reliable and sustainable dividend. That said, it is also one of the riskier pharma stocks right now. Crown Castle may not be the best-known S ...

Owning stocks with big dividends might finally start paying off. Dividend-paying stalwarts such as JPMorgan Chase and Merck are primed to fare better in the coming year, some investors said.

Its quarterly dividend payment ... just identified what they believe are the 10 best stocks for investors to buy now… and Royalty Pharma Plc wasn’t one of them. The 10 stocks that made ...

Royalty Pharma (NASDAQ: RPRX), W.P. Carey (NYSE ... At their beaten-down prices, these stocks offer juicy dividend yields, and there's a good chance they can maintain or raise their payouts ...